Volition is developing simple, easy to use blood-based Nu.Q™ immunoassay tests to accurately diagnose a range of cancers. Our first test, the Nu.Q™ colorectal cancer screening triage test, identifies patients who have received a false positive result on their FIT test and ensures that fewer patients are referred for unnecessary colonoscopies. Diagnostic Nu.Q™ tests for people with symptoms indicating colorectal cancer as well as a screening test for average risk populations are in development.
Included in the Export Interest Directory? No
Business Needs: Direct Sales, Distributor/Agent/Representative, Licensing Agreements
Products to be exported: The Nu.Q™ colorectal cancer screening triage test identifies patients with a false positive result on their FIT test and ensure that fewer patients are referred for unnecessary colonoscopies.